Skip to main content

Sklamberg Quoted in The Pink Sheet on Woodcock FDA Tenure

December 6, 2021

Life Sciences & Healthcare Regulatory partner Howard Sklamberg was quoted in a recent article from The Pink Sheet, “She Didn’t Need to Be Commissioner: Janet Woodcock’s Transformative Legacy.” The article discusses acting commissioner Janet Woodcock’s 35-year career at the US Food and Drug Administration (FDA). Sklamberg, who held a variety of roles at the FDA from 2010 to 2017, comments on Woodcock’s knowledge across disciplines and management skills, as well as her influence on how the agency handles drug regulation and development.

» Read the full article (subscription required).